Access cutting-edge alpha-1 antitrypsin deficiency treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access alpha-1 antitrypsin deficiency specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alpha-1 antitrypsin deficiency treatment provided free
Phase 2 open label extension study to evaluate SAR447537 (INBRX-101) in adults with AATD emphysema
Sponsor: Sanofi
Check if you qualify for this alpha-1 antitrypsin deficiency clinical trial in Indianapolis, IN
If you're searching for alpha-1 antitrypsin deficiency treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alpha-1 antitrypsin deficiency specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.